Fentanyl Sublingual Spray for the Treatment of Acute Procedure-related Pain in a Monitored Setting

Summary

Participants will be selected from patients who have been scheduled at the site for treatment of chronic pain without sedation. They will receive either fentanyl sublingual spray or a matching placebo sublingual spray that delivers no medication. Participants may take pain killers at any time after the procedure for pain relief. They will be given a diary card, which they will take home. They will record the name of the medication taken, the time, and dosage. The study coordinator will call participants about 24 hours after the procedure to collect information from the diary card and follow up information about pain and side effects (adverse events) after they left the site.

Timeline

Start

2017-12-30

Primary completion

2018-01

Completion

2018-01

Drugs

Indications